Camrelizumab for Advanced-Stage Esophageal Cancer, Urate-Elevating Inosine for Early Parkinson Disease, Low- vs High-Normal Oxygen Targets in the ICU, and more episode artwork

EPISODE · Sep 14, 2021 · 12 MIN

Camrelizumab for Advanced-Stage Esophageal Cancer, Urate-Elevating Inosine for Early Parkinson Disease, Low- vs High-Normal Oxygen Targets in the ICU, and more

from JAMA Editors' Summary

Editor's Summary by Gregory Curfman, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the September 14, 2021 issue.

Episode metadata supplied by the publisher feed · Published Sep 14, 2021

Embed this episode

NOW PLAYING

Camrelizumab for Advanced-Stage Esophageal Cancer, Urate-Elevating Inosine for Early Parkinson Disease, Low- vs High-Normal Oxygen Targets in the ICU, and more

0:00 12:36

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JAMA Editors' Summary?

This episode is 12 minutes long.

When was this JAMA Editors' Summary episode published?

This episode was published on September 14, 2021.

Can I download this JAMA Editors' Summary episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!